Trial · NCT02231918
Results by group261
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 261
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cmax,ss | PPX (MIRAPEX®, 0.125 mg) | 6 to <12 years (N=5, 9, 0) | 0.633 | Geometric Coefficient of Variation 26.2 | ng/mL |
| Cmax,ss | PPX (MIRAPEX®, 0.25 mg) | 6 to <12 years (N=5, 9, 0) | 1.13 | Geometric Coefficient of Variation 35.3 | ng/mL |
| Cmax,ss | PPX (MIRAPEX®, 0.5 mg) | 6 to <12 years (N=5, 9, 0) | NA | Geometric Coefficient of Variation NA | ng/mL |
| Cmax,ss | PPX (MIRAPEX®, 0.125 mg) | 12 to <18 years(N=4, 6, 2)) | 0.396 | Geometric Coefficient of Variation 30.0 | ng/mL |
| Cmax,ss | PPX (MIRAPEX®, 0.25 mg) | 12 to <18 years(N=4, 6, 2)) | 0.677 | Geometric Coefficient of Variation 40.3 | ng/mL |
| Cmax,ss | PPX (MIRAPEX®, 0.5 mg) | 12 to <18 years(N=4, 6, 2)) | NA | Geometric Coefficient of Variation NA | ng/mL |
| Cmin,ss | PPX (MIRAPEX®, 0.125 mg) | 6 to <12 years (N=5, 9, 0) | 0.0872 | Standard Deviation 35.5 | ng/mL |
| Cmin,ss | PPX (MIRAPEX®, 0.25 mg) | 6 to <12 years (N=5, 9, 0) | 0.136 | Standard Deviation 99.5 | ng/mL |
| Cmin,ss | PPX (MIRAPEX®, 0.5 mg) | 6 to <12 years (N=5, 9, 0) | NA | Standard Deviation NA | ng/mL |
| Cmin,ss | PPX (MIRAPEX®, 0.125 mg) | 12 to <18 years(N=4, 6, 2) | 0.0972 | Standard Deviation 37.5 | ng/mL |
| Cmin,ss | PPX (MIRAPEX®, 0.25 mg) | 12 to <18 years(N=4, 6, 2) | 0.122 | Standard Deviation 53.8 | ng/mL |
| Cmin,ss | PPX (MIRAPEX®, 0.5 mg) | 12 to <18 years(N=4, 6, 2) | NA | Standard Deviation NA | ng/mL |
| Cpre,N | PPX (MIRAPEX®, 0.125 mg) | 6 to <12 years (N=4, 8, 0) | 0.074 | Geometric Coefficient of Variation 17.3 | ng/mL |
| Cpre,N | PPX (MIRAPEX®, 0.25 mg) | 6 to <12 years (N=4, 8, 0) | 0.147 | Geometric Coefficient of Variation 75.3 | ng/mL |
| Cpre,N | PPX (MIRAPEX®, 0.5 mg) | 6 to <12 years (N=4, 8, 0) | NA | Geometric Coefficient of Variation NA | ng/mL |
| Cpre,N | PPX (MIRAPEX®, 0.125 mg) | 12 to <18 years (N=1, 5, 1) | NA | Geometric Coefficient of Variation NA | ng/mL |
| Cpre,N | PPX (MIRAPEX®, 0.25 mg) | 12 to <18 years (N=1, 5, 1) | 0.112 | Geometric Coefficient of Variation 60.7 | ng/mL |
| Cpre,N | PPX (MIRAPEX®, 0.5 mg) | 12 to <18 years (N=1, 5, 1) | NA | Geometric Coefficient of Variation NA | ng/mL |
| Cavg | PPX (MIRAPEX®, 0.125 mg) | 6 to <12 years (N=5, 8, 0) | 0.213 | Geometric Coefficient of Variation 27.4 | ng/mL |
| Cavg | PPX (MIRAPEX®, 0.25 mg) | 6 to <12 years (N=5, 8, 0) | 0.458 | Geometric Coefficient of Variation 42.8 | ng/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02231918/results